Looking forward to MCTC CAR-T webinar @MctcMyositis
Join us for “Latest Advances in CAR T-Cell Therapy for Inflammatory Myopathies,” featuring Dr. Vikas Majithia and moderated by Dr. Mathilde Bandeira.
📅 September 25, 2026
⏰ 10 AM ET
🔗 lnkd.in/eZH-WTq9#Myositis#CAR
🚨#Myositis Breaking News: FDA approves the 1st-ever oral targeted therapy for #Dermatomyositis — brepocitinib (Lisraya), a JAK1/TYK2 inhibitor. With Brepo + IVIG now approved, it’s time to reduce our reliance on long-term steroids. Big step forward ! 🎉 fda.gov/news-events/press-an…
Novel tx for Myositis : After IVIG (ProDERM by Octapharma) & Brepocitinib (Valor by Priovant) in DM, for the first time we have highly positive phase 3 trial for IMNM & DM. Efgartogimod SQ (anti-FcRN) showed significant improvement in IMNM & DM vs. PBO.
argenx.com/news/2026/press-r…
MCTC Webinar: CAR-T Cell Therapy Advances in Inflammatory Myopathies
Join Dr. Vikas Majithia (Mayo Clinic Jacksonville) one with most experience in CAR-T, moderated by Dr. Matilde Bandeira, for the research updates.
📅 Sept. 25, 2026 | 10 AM EST
#CART#Myositis#MCTC#Researchnitter.net/docrota/status/2082210…
Myositis India invites MD/DNB/DM/DrNB trainees to participate in the Enigmatic Case Presentation Competition 2026. Submit a 300-word abstract on an interesting myositis-related case. Winners will be felicitated at IRACON 2026. Deadline: 15 Jul 2026. #MyositisIndia#IRACON2026
Medical trainees, present your interesting myositis case before the Stalwarts of Rheumatology!
Myositis India invites submissions for the 2026 Enigmatic Case Presentation Competition.
Open to MD, DNB, DM & DrNB trainees.
Deadline: 15-07-2026
Email: academics@myositisindia.org
This Myositis Awareness Month, we share the inspiring journey of our ambassador @Samanthaprabhu2 , who faced Myositis with courage and continues to inspire patients, caregivers, & supporters.
@Myositis_India is here for you at every step.
Donate: myositisindia.org/donate@docrota
Join Myositis India for the Physician Webinar on “Interferons in IIM” on 31 May 2026 | 8 PM IST.
Featuring Dr. Akira Yoshida & Dr. Rudrarpan Chatterjee.
Register here: forms.gle/Z3nP1czznbnL1Q3f7#Myositis#Rheumatology#IIM
Understanding Interferons in IIM: from pathogenesis to clinical relevance.
Join Myositis India for a webinar on interferon signatures, their role in IIM, and what it means for clinical practice.
🗓 31 May 2026
⏰ 8 PM IST
📍 Zoom
Scan QR to register.
One voice can inspire thousands to feel seen, heard, & hopeful. More than an interview — a conversation that brings strength to the myositis community. Grateful to Samantha Ruth Prabhu a Bollywood star for using her voice to spread myositis awareness.
Wishing Samantha Ruth Prabhu (@Samanthaprabhu2) a very Happy Birthday! 🎂💙
Her courage in openly sharing her myositis journey has been a beacon of hope for countless patients across India. Today, the entire myositis community comes together to celebrate her strength, resilience, and the powerful voice she lends to our cause. Your strength gives us hope. Your voice helps us be heard. 🌿
#HappyBirthdaySamantha#MyositisIndia#StrengthSupportAwareness#SamanthaRuthPrabhu
The most exciting news ever for myositis pts: a novel oral JAK1/TYK2 inhibitor (brepocitinib) shows positive Phase 3 results in dermatomyositis. Honored to part of the VALOR & NEJM- grateful to our patients, investigators, and Priovant. FDA Approval soon. nejm.org/doi/abs/10.1056/NEJ…
Clinical trials aren’t optional in myositis, they’re the backbone of evidence-based care.
Join leading experts to discuss key challenges, barriers, and the way forward.
🗓 8 Feb 2026 | SUNDAY |⏰ 7 PM IST
📲 Register via QR
#Myositis#ClinicalTrials#Rheumatology
Clinical trials aren’t optional in myositis, they’re the backbone of evidence-based care.
Join leading experts to discuss key challenges, barriers, and the way forward.
🗓 8 Feb 2026 | SUNDAY |⏰ 7 PM IST
📲 Register via QR
#Myositis#ClinicalTrials#Rheumatology
Sharing our editorial on CTD-ILD in Rheumatology (Oxford). Thanks to Dr. Shiri Keret and Daniel Sullivan for this article. Interstitial lung disease in connective tissue diseases: evolving strategies across the disease spectrum academic.oup.com/rheumatolog…
Looking for a Project Manager for MCTC (Remote work position). See job posting below. Exciting work in scientific and global environments for a rare disease organization.
🚨 NEW DEADLINE The MCTC grants to support early-career investigators 👨🔬 attending the Global Conference on Myositis (GCOM) 2026 will be open for submissions for a couple of extra weeks! Applications are now due by November 15, 2025. #MCTC#GCOM2026#EarlyCareerResearchers
🚀 CANTRAIN is revolutionizing clinical trial research in Canada. Discover how their approach is transforming training, engagement & impact.📷 Join us on November 7 at 10:00 AM EST-->
can01.safelinks.protection.o…📷🕓